Noradrenergic neuron-specific overexpression of nNOS in cardiac sympathetic nerves decreases neurotransmission

Journal of Molecular and Cellular Cardiology

Volumn 41, Issue 2, 2006, Pages 364-370

  Wang, L ^a   Li, D ^a   Plested, C P ^a   Dawson, T ^a   Teschemacher, A G ^b   Paterson, D J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Gene transfer; Heart; Neurotransmission; nNOS; Norepinephrine

Indexed keywords

ADENOVIRUS VECTOR; CHOLINE ACETYLTRANSFERASE; ENHANCED GREEN FLUORESCENT PROTEIN; N(G) NITROARGININE; NEURONAL NITRIC OXIDE SYNTHASE; NORADRENALIN; PLASMID VECTOR; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CELL TYPE; CHOLINERGIC ACTIVITY; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG ACTIVITY; DRUG TARGETING; EXPRESSION VECTOR; GANGLION; GENE CONSTRUCT; GENE OVEREXPRESSION; GENE TRANSFER; HEART NERVE; HEART STIMULATION; INHIBITION KINETICS; ISOLATED HEART; NEUROTRANSMISSION; NEWBORN; NONHUMAN; NORADRENALIN RELEASE; NORADRENERGIC NERVE; PRESYNAPTIC NERVE; PRIORITY JOURNAL; PROMOTER REGION; RAT; SIGNAL TRANSDUCTION; SYMPATHETIC NERVE; SYMPATHETIC TONE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; AGING; ANIMALS; ANIMALS, NEWBORN; GENE EXPRESSION; HEART ATRIA; HEART CONDUCTION SYSTEM; NEURONS; NITRIC OXIDE SYNTHASE TYPE I; NOREPINEPHRINE; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOMIMETICS; TRANSDUCTION, GENETIC;

ADENOVIRIDAE;

EID: 33746099695     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2006.05.007     Document Type: Article

References (19)

1. Channon K.M., Blazing M.A., Shetty G.A., Potts K.E., and George S.E. Adenoviral gene transfer of nitric oxide synthase: high level expression in human vascular cells. Cardiovasc. Res. 32 5 (1996) 962-972
2. Ren J., Zhang X., Scott G.I., Glende I., Esberg L.B., Ren B.H., et al. Adenovirus gene transfer of recombinant endothelial nitric oxide synthase enhances contractile function in ventricular myocytes. J. Cardiovasc. Pharmacol. 43 2 (2004) 171-177
3. Mohan R.M., Golding S., Heaton D.A., Danson E.J., and Paterson D.J. Targeting neuronal nitric oxide synthase with gene transfer to modulate cardiac autonomic function. Prog. Biophys. Mol. Biol. 84 2-3 (2004) 321-344
4. Li Y., Roy S.K., Channon K.M., Zucker I.H., and Patel K.P. Effect of in vivo gene transfer of nNOS in the PVN on renal nerve discharge in rats. Am. J. Physiol., Heart Circ. Physiol. 282 2 (2002) H594-H601
5. Mohan R.M., Heaton D.A., Danson E.J., Krishnan S.P., Cai S., Channon K.M., et al. Neuronal nitric oxide synthase gene transfer promotes cardiac vagal gain of function. Circ. Res. 91 12 (2002) 1089-1091
6. Paton J.F., Kasparov S., and Paterson D.J. Nitric oxide and autonomic control of heart rate: a question of specificity. Trends Neurosci. 25 12 (2002) 626-631
7. Kootstra N.A., and Verma I.M. Gene therapy with viral vectors. Annu. Rev. Pharmacol. Toxicol. 43 (2003) 413-439
8. Schwarz P., Diem R., Dun N.J., and Forstermann U. Endogenous and exogenous nitric oxide inhibits norepinephrine release from rat heart sympathetic nerves. Circ. Res. 77 4 (1995) 841-848
9. Choate J., and Paterson D.J. Neuronal nitric oxide inhibits the positive chronotropic and inotropic responses to sympathetic nerve stimulation in vitro. J. Auton. Nerv. Syst. 75 2-3 (1999) 100-108
10. Hwang D.Y., Carlezon Jr. W.A., Isacson O., and Kim K.S. A high-efficiency synthetic promoter that drives transgene expression selectively in noradrenergic neurons. Hum. Gene. Ther. 12 14 (2001) 1731-1740
11. He T., Zhou S., Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U S A 95 5 (1998) 2509-2514
12. +-channel activators and inhibitors in guinea-pig and human isolated right atrium. Cardiovasc. Res. 43 (1999) 125-134
13. Bia B.L., Cassidy P.J., Young M.E., Rafael J.A., Leighton B., Davies K.E., et al. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of duchenne muscular dystrophy. J. Mol. Cell Cardiol. 31 10 (1999) 1857
14. Wehling-Henricks M., Jordan M.C., Roos K.P., Deng B., and Tidball J.G. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum. Mol. Genet. 14 14 (2005) 1921-1933
15. Schlaich M.P., Lambert E., Kaye D.M., Krozowski Z., Campbell D.J., Lambert G., et al. Sympathetic augmentation in hypertension: role of nerve firing, norepinephrine reuptake, and angiotensin neuromodulation. Hypertension 43 2 (2004) 169-175
16. Rundqvist B., Elam M., Bergmann-Sverrisdottir Y., Eisenhofer G., and Friberg P. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95 1 (1997) 169-175
17. Vatner D.E., and Vatner S.F. Physiological and biochemical adrenergic regulation of the stunned myocardium. Mol. Cell Biochem. 186 1-2 (1998) 131-137
18. Danson E.J., Choate J.K., and Paterson D.J. Cardiac nitric oxide: emerging role for nNOS in regulating physiological function. Pharmacol. Ther. 106 1 (2005) 57
19. Saraiva R.M., Minhas K.M., Raju S.V.Y., Barouch L.A., Pitz E., Schuleri K.H., et al. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation 112 22 (2005) 3415-3422